Barriers to compliance with prophylaxis therapy in haemophilia

被引:234
|
作者
Hacker, MR [1 ]
Geraghty, S [1 ]
Manco-Johnson, M [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA
关键词
children; compliance; haemophilia; prophylaxis;
D O I
10.1046/j.1365-2516.2001.00534.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prophylaxis, or the practice of routine replacement infusions of clotting factor concentrate in persons with severe haemophilia, is a demanding medical regimen. Prophylactic infusions require direct venepuncture or sterile entry into a central venous access device on a regular basis. A telephone survey was conducted to elicit information regarding the barriers to compliance with prophylaxis. The Mountain States Regional Haemophilia and Thrombosis Center has recommended prophylaxis to 52 male patients with haemophilia A or B. The haemophilia nurse attempted to contact all of these patients or their parents, and contact was made with 38 (73.1%) of them. Respondents were asked about the following issues: their decision to initiate prophylaxis; their self-rated compliance; the challenges, barriers, and facilitators of prophylaxis; and their perceived value of the therapy. Four patients (10.5%) elected not to begin prophylaxis. Of the 34 persons who began prophylaxis, 20 respondents (58.8%) rated their compliance as excellent. Nearly one-third of the families with excellent compliance (giving 75-100% of prescribed infusions) stated that the time-consuming nature of prophylaxis was the most significant challenge of the regimen. In addition, 58.3% of the families that gave less than the prescribed number of infusions reported that the time commitment was the primary reason for missing infusions. Knowledge of the benefits of prophylaxis was the primary facilitator of compliance for 44.1% of families. Ninety-seven percent of respondents rated prophylaxis as very valuable. These data show that despite the known benefits of prophylaxis, it is a demanding medical regimen, and compliance is imperfect. In addition, this study underscores the importance of providing continuing support and education for patients and families who are implementing prophylaxis.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 50 条
  • [31] Optimising prophylaxis in haemophilia A: The ups and downs of treatment
    Berntorp, Erik
    Hermans, Cedric
    Solms, Alexander
    Poulsen, Lone
    Mancuso, Maria Elisa
    BLOOD REVIEWS, 2021, 50
  • [32] Haemophilia care in adolescents - compliance and lifestyle issues
    Petrini, P.
    Seuser, A.
    HAEMOPHILIA, 2009, 15 : 15 - 19
  • [33] Compliance with malaria prophylaxis in children
    Minodier, P
    Noël, G
    Blanc, P
    Retornaz, K
    Garnier, JM
    ARCHIVES DE PEDIATRIE, 2005, 12 (06): : 787 - 788
  • [34] A Comparison of the Incidence Rate for Joint Bleeding and FVIII Consumption between On-Demand versus Prophylaxis Factor VIII Replacement Therapy and the Direct Cost of Prophylaxis Treatment in Severe Haemophilia A Patients
    Jamal, Munirah
    Sathar, Jameela
    Jamari, Jamaliah
    Saffian, Shamin Mohd
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2023, 30 (01): : 129 - 136
  • [35] Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future
    Jimenez-Yuste, Victor
    Auerswald, Guenter
    Benson, Gary
    Lambert, Thierry
    Morfini, Massimo
    Remor, Eduardo
    Salek, Silva Zupancic
    BLOOD TRANSFUSION, 2014, 12 (03) : 314 - 319
  • [36] Prophylaxis in patients with haemophilia: introduction
    Chambost, H.
    HAEMOPHILIA, 2010, 16 : 1 - 3
  • [37] Prophylaxis in haemophilia B - Prevention of bleeds and FIX consumption
    Siegmund, B.
    Richter, H.
    Pollmann, H.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S35 - S36
  • [38] Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors
    Rodriguez-Merchan, E. C.
    Valentino, L.
    Quintana, M.
    HAEMOPHILIA, 2007, 13 : 45 - 48
  • [39] Translating the success of prophylaxis in haemophilia to von Willebrand disease
    Miesbach, Wolfgang
    Berntorp, Erik
    THROMBOSIS RESEARCH, 2021, 199 : 67 - 74
  • [40] Haemophilia A patients' medication adherence to prophylaxis with efmoroctocog alfa
    Pitance, Victoire
    Desage, Stephanie
    Lienhart, Anne
    Meunier, Sandrine
    Chamouard, Valerie
    HAEMOPHILIA, 2021, 27 (03) : E368 - E375